Toxic Exposures Investigator-Initiated Research Award
ID: 355155Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355155
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Toxic Exposures Investigator-Initiated Research Award to support research initiatives focused on health outcomes related to military-related toxic exposures. This grant aims to advance studies in areas such as prevention, diagnosis, and treatment of conditions like neurotoxin exposure and Gulf War Illness, encouraging hypothesis-driven projects that may involve collaborations with Department of Defense and Veterans Affairs researchers. With an estimated total program funding of $3.2 million and the expectation of awarding four grants, interested applicants must submit a pre-application by August 13, 2024, followed by a full application by November 7, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524TERPIIRA-GG.pdf
    The Department of Defense (DOD) is announcing the FY24 Toxic Exposures Investigator-Initiated Research Award as part of the Defense Health Program, specifically under the Toxic Exposures Research Program (TERP). This funding opportunity aims to advance research on the prevention, diagnosis, treatment, and understanding of health outcomes linked to military-related toxic exposures. The program has an appropriation of $30 million for FY24 and encourages applications that target at least one of the program goals and topic areas, such as neurotoxin exposure and Gulf War Illness. Key submission dates include a pre-application deadline on August 13, 2024, and a full application deadline by November 7, 2024. Applicants can be a diverse range of organizations, including academia and private sectors, and must ensure their projects are hypothesis-driven and relevant to military health. Special emphasis is placed on collaborations with DOD and Veterans Affairs researchers. The application process consists of a two-step submission via the Electronic Biomedical Research Application Portal (eBRAP) and Grants.gov. This announcement is critical in an ongoing effort to address the adverse health implications arising from toxic exposures experienced by Service Members, Veterans, and their families, reflecting the DOD's commitment to improving health outcomes and patient care.
    Similar Opportunities
    DOD Glioblastoma, Transformative Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Glioblastoma Transformative Consortium Award, aimed at advancing research to improve outcomes for glioblastoma patients. This grant seeks proposals for innovative, multidisciplinary projects that collectively address a central hypothesis, requiring collaboration among at least four distinct projects and the inclusion of a consumer advocate. With an estimated total program funding of $9 million, the application process includes a pre-application deadline of December 23, 2024, and a full application deadline of January 13, 2025. Interested applicants can reach the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Funding Opportunity Title:Deployed Warfighter Protection (DWFP) Program for the Protection of Deployed Military Personnel from Threats Posed by Arthropod Disease Vectors
    Active
    Department of Defense
    The Department of Defense is offering a funding opportunity through the Fiscal Year 2025 Deployed Warfighter Protection (DWFP) Program, aimed at safeguarding military personnel from threats posed by arthropod disease vectors. The program seeks innovative research proposals focused on developing new insecticides, personal protection technologies, and improved vector control strategies, with applications required to address specific research areas such as bite prevention, vector control, and diagnostics. This initiative is crucial for enhancing health protection in military operations and has a total estimated funding of $5 million, with individual awards capped at $975,000 over three years. Interested applicants must submit a pre-application by October 4, 2024, and a full application by January 28, 2025; for further inquiries, contact Scott I. Hoffman at scott.i.hoffman2.civ@army.mil or call 1-520-671-1470.
    CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms," aimed at supporting research into the mechanisms of chemical toxicity affecting the lungs and eyes. This initiative seeks to fund projects that explore the health impacts of chemical threat agents, with a focus on identifying molecular and genetic targets for therapeutic countermeasures, utilizing various research methodologies such as animal models and computational modeling. A total of approximately $3 million is available to support up to five grants, with each project eligible for a maximum budget of $300,000 per year over a three-year period. Interested applicants should note that the application period opens on August 24, 2024, with a final submission deadline of September 24, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System." This initiative invites applications for basic research projects focused on understanding the mechanisms of toxicity of chemical warfare agents and toxic industrial chemicals that impact the nervous system, with the aim of developing potential therapeutic countermeasures for civilian exposure. The program is particularly significant in enhancing public health responses to chemical threats, emphasizing innovative and transdisciplinary research approaches. Up to four grants totaling $2 million are anticipated for fiscal year 2026, with applications due by 5 PM local time on October 17, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Airman Readiness Medical Research (ARMR) Hybrid BAA
    Active
    Air Force -- Research Lab
    The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
    Department of Defense HIV/AIDS Prevention Program
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Fundamental Research to Counter Weapons of Mass Destruction
    Active
    Defense Threat Reduction Agency
    The Defense Threat Reduction Agency (DTRA) has announced a Broad Agency Announcement (BAA) for fundamental research aimed at countering Weapons of Mass Destruction (WMD), with funding available from October 1, 2024, to September 30, 2034. This opportunity invites proposals from accredited colleges, universities, and research entities to contribute to DTRA's mission of reducing WMD threats, emphasizing collaboration in areas such as chemical and biological defense. The funding will primarily be awarded as grants, with amounts ranging from $25,000 to $1 million annually, and proposals will undergo a two-phase evaluation process assessing scientific merit and mission relevance. Interested applicants should submit pre-application white papers and can direct inquiries to the BAA Administrative Mailbox at dtra.belvoir.rd.mbx.rd-cb-frbaa25-34-a@mail.mil before the closing date of September 30, 2034.
    Department of Army Energetics Basic Research Center (EBRC) Fiscal Year 2025
    Active
    Dept of the Army -- Materiel Command
    The Department of the Army, through the Materiel Command, is offering a funding opportunity for the Energetics Basic Research Center (EBRC) for Fiscal Year 2025, aimed at advancing research in energetic materials (EM) critical to U.S. national security. This initiative invites eligible applicants, including universities, nonprofit organizations, state and local governments, and for-profit entities, to submit white papers and proposals that focus on innovative research in EMs, particularly in areas such as novel materials, microstructure influence, and advanced diagnostics. The program is designed to enhance the Army's capabilities in developing new materials and technologies that improve weapon systems' performance and effectiveness, with a total funding ceiling of $1 million anticipated for up to six awards ranging from $60,000 to $250,000 per year. Interested parties should submit white papers by January 6, 2025, and proposals by invitation by April 7, 2025; for further inquiries, contact Schon Zwakman at schon.m.zwakman.civ@army.mil or by phone at 919-541-4722.
    US Army Combat Capabilities Development Command Broad Agency Announcement
    Active
    ACC APG - Natick
    The US Army Combat Capabilities Development Command (CCDC) is inviting proposals through its Broad Agency Announcement (BAA) for research and development funding, managed by the ACC APG - Natick. This opportunity allows unrestricted applicants to submit white papers and proposals for grants and assistance agreements, focusing on various areas of interest outlined in the BAA solicitation document. The initiative is crucial for advancing the capabilities of the Army, with an expected 50 awards to be made. Interested parties should note that the submission deadline is February 28, 2025, and can reach out to Shawn P. Haubner at shawn.p.haubner.civ@mail.mil or by phone at 508-206-2067 for further information.